Urigen Tablet

About Urigen 1 mg Tablet

Urigen 1 mg tablet is a medicine made by Orion Pharma Ltd. Only a doctor can confirm whether your symptoms are due to overactive bladder and whether this medicine is suitable for you.

There are 6 brands of Tolterodine Tartrate listed in Bangladesh. The lowest listed price is Tolter 1 mg Tablet at ৳ 3.00 per unit.

What is Urigen 1 mg Tablet?

Urigen 1 mg is a tablet product of Orion Pharma Ltd. that contains Tolterodine Tartrate. Doctors prescribe it for overactive bladder, where people feel a sudden strong need to pass urine, go often, or leak urine before reaching the toilet. It is a muscarinic receptor antagonist, a medicine that acts on the bladder muscle. The doctor decides the dose and how long you take it.

Uses of Urigen

Only a doctor can confirm whether your symptoms are due to overactive bladder and whether this medicine is suitable for you. This condition causes a sudden, strong urge to urinate, passing urine more often than usual, and sometimes urge incontinence, where urine leaks before you reach the toilet. Urigen is used to treat overactive bladder. Ask your doctor whether it is right for your condition.

How to use Urigen

Take Urigen exactly as your doctor tells you. Urigen is taken by mouth. Swallow the tablet with water. The doctor decides the dose, how often to take it and how long the course should last. Complete the course exactly as prescribed.

Side effects of Urigen

Ask them about anything you notice while taking this medicine, and do not treat side effects yourself without advice. It may cause mild to moderate antimuscarinic effects, such as a dry mouth, indigestion or reduced tear production. Like other medicines, Urigen can cause side effects. Tell your doctor or pharmacist if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

It should not be used by people with urinary retention, uncontrolled narrow angle glaucoma, or a known allergy to tolterodine or any ingredient of the tablet. There are no studies in pregnant women, so it is used in pregnancy only if the doctor judges the benefit outweighs the risk. It should be avoided during breastfeeding because there is no data on its passing into breast milk. Ask your doctor first if you are at risk of urinary retention, have reduced gut movement, or have kidney or liver problems.

Frequently asked questions

Why is Urigen prescribed?

Only a doctor can confirm whether your symptoms are due to overactive bladder and whether this medicine is suitable for you. This condition causes a sudden, strong urge to urinate, passing urine more often than usual, and sometimes urge incontinence, where urine leaks before you reach the toilet.

How do I use Urigen correctly?

Take Urigen exactly as your doctor tells you. Urigen is taken by mouth.

What should I watch for while using Urigen?

Ask them about anything you notice while taking this medicine, and do not treat side effects yourself without advice. It may cause mild to moderate antimuscarinic effects, such as a dry mouth, indigestion or reduced tear production.

Who should be careful with Urigen?

It should not be used by people with urinary retention, uncontrolled narrow angle glaucoma, or a known allergy to tolterodine or any ingredient of the tablet. There are no studies in pregnant women, so it is used in pregnancy only if the doctor judges the benefit outweighs the risk.

Indications

Tolterodine Tartrate is indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Pharmacology

Tolterodine is a competitive, specific muscarinic receptor antagonist which exhibits a selectivity for the urinary bladder over salivary glands, which have been demonstrated in non clinical pharmacological in vivo studies. Tolterodine has a high specificity for muscarinic receptors. A major active metabolite (5-hydroxymethyl derivative) of tolterodine exhibits a pharmacological profile which is similar to that of the parent compound. In extensive metabolisers this metabolite contributes significantly to the therapeutic effect of tolterodine. The effect of treatment can be expected within 4 weeks.

Dosage & Administration

The recommended dose for tolterodine is 2 mg twice daily. In case of troublesome side effects the dose may be reduced from 2 mg to 1 mg twice daily.

The recommended total daily dose of tolterodine is 2 mg (1 mg b.i.d.) for patients with impaired renal function, impaired liver function, or receiving concomitant medication with potent CYP3A inhibitors, such as macrolide antibiotics (e.g. erythromycin and clarithromycin) or azole antifungal agents (e.g. ketoconazole, itraconazole and miconazole). After six months the need for further treatment should be considered.

Interaction

Pharmacokinetic interactions are possible with other drugs metabolised by or inhibiting cytochrome P450 2D6 (CYP2D6) or CYP3A4. Concomitant treatment with fluoxetine does not result in a clinically significant interaction.

Ketoconazole, a potent inhibitor of CYP3A, significantly increased plasma concentrations of tolterodine when coadministered to poor metabolisers (i.e. persons devoid of CYP2D6 metabolic pathway).

Clinical studies have shown no interactions with warfarin or combined oral contraceptives (ethinyloestradiol or levonorgestrel).

Contraindications

Tolterodine is contraindicated in those patients with urinary retention, uncontrolled narrow angle glaucoma, known hypersensitivity to tolterodine or any other component of the drug.

Side Effects

Tolterodine may cause mild to moderate antimuscarinic effects, like dryness of mouth, dyspepsia and/or reduced lacrimation.

Pregnancy & Lactation

There are no studies in pregnant women. Therefore, tolterodine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Use of tolterodine during lactation should be avoided since no data on excretion of the drug into breast milk in humans is available.

Precautions & Warnings

Tolterodine should be used with caution in the following patients:
  • at risk for urinary retention
  • at risk for decreased gastrointestinal motility
  • with impaired renal function
  • with impaired hepatic function
Organic reasons for urge and frequency should be considered before treatment.

Overdose Effects

Overdosage with Tolterodine Tartrate capsules can potentially result in severe central anticholinergic effects and should be treated accordingly. ECG monitoring is recommended in the event of overdosage.

Storage Conditions

Store in a cool and dry place. Protect from light. Keep out of the reach of children.

Alternative brands of Tolterodine Tartrate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.